ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.
ThinkGenetic
Finding Patients At Risk for Rare Disease
Together let’s systematically accelerate detecting at-risk individuals.
ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.